EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Benzimidazole–dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions

Heba T Abdel-Mohsen iD, Amira M Nageeb

RSC Advances · 2024 · 14 (39) · 28889-28903

DOI: 10.1039/d4ra05462h ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2024. Verfasst von Heba T Abdel-Mohsen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre Dokki P.O. 12…. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Science and Technology Development Fund.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of new benzimidazole–dioxo(benzo)isoindoline conjugates were designed and synthesized as dual VEGFR-2 and FGFR-1 inhibitors. Compound 8m demonstrated potent % inhibition of 80.69% and 76.83% on VEGFR-2 and FGFR-1 at 10 μM, respectively.

Autor:innen und Institutionen

  • Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre Dokki P.O. 12622 Cairo Egypt hebabdelmohsen@gmail.com ht.abdel-mohsen@nrc.sci.eg.
  • High Throughput Molecular and Genetic Technology Lab, Center of Excellence for Advanced Sciences, Biochemistry Department, Biotechnology Research Institute, National Research Centre Dokki P.O. 12622 Cairo Egypt.

ORCID-Profile: Heba T Abdel-Mohsen

Förderung

  • Science and Technology Development Fund

Zitieren

APA

Abdel-Mohsen, H. T., & Nageeb, A. M. (2024). Benzimidazole–dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions. RSC Advances, 14(39), 28889-28903. https://doi.org/10.1039/d4ra05462h

Vancouver

Abdel-Mohsen HT, Nageeb AM. Benzimidazole–dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions. RSC Advances. 2024;14(39):28889-28903. doi:10.1039/d4ra05462h

BibTeX
@article{AbdelMohsen2024,
  author = {Abdel-Mohsen, Heba T and Nageeb, Amira M},
  title = {Benzimidazole–dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions},
  journal = {RSC Advances},
  year = {2024},
  volume = {14},
  number = {39},
  pages = {28889--28903},
  doi = {10.1039/d4ra05462h}
}
Kostenlos starten →